Evidence map›Paper›PMID 20703838›Full record

ReviewCurrent gastroenterology reports2010

Intestinal goblet cells and mucins in health and disease: recent insights and progress.

Young S Kim, Samuel B Ho

Open access · hybridAbstract readReview
In one paragraph

Review in Current gastroenterology reports, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 598 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
598citing papers in PubMed, 2 pooled it
17.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

598 citing papers in PubMed, 2 syntheses or guidelines pooled it, 1,379 citations in OpenAlex.

  1. Frontiers in nutrition · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. From triggers to interfaces: polymer-stabilized nano-co-crystals for robust mesalazine delivery in UC.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2026
    Review
  5. Effects ofJournal of animal science and technology · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. AMarine drugs · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Biomolecules · 2026
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

538 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Young S KimGenemed Biotechnologies, 458 Carlton Court, South San Francisco, CA 94080, USA. young.kim@ucsf.edu
Samuel B Ho
University of California, San Francisco · USVA San Diego Healthcare System · US

Funding

The UCSD Digestive Diseases Research Development CenterR24DK080506 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ECKMANN, LARS · 2008 to 2012
$2.7M
NIDDK NIH HHS DK080506NIDDK NIH HHS R24 DK080506
6 · The paper itself

Abstract

The mucus layer coating the gastrointestinal tract is the front line of innate host defense, largely because of the secretory products of intestinal goblet cells. Goblet cells synthesize secretory mucin glycoproteins (MUC2) and bioactive molecules such as epithelial membrane-bound mucins (MUC1, MUC3, MUC17), trefoil factor peptides (TFF), resistin-like molecule beta (RELMbeta), and Fc-gamma binding protein (Fcgbp). The MUC2 mucin protein forms trimers by disulfide bonding in cysteine-rich amino terminal von Willebrand factor (vWF) domains, coupled with crosslinking provided by TFF and Fcgbp proteins with MUC2 vWF domains, resulting in a highly viscous extracellular layer. Colonization by commensal intestinal microbiota is limited to an outer "loose" mucus layer, and interacts with the diverse oligosaccharides of mucin glycoproteins, whereas an "inner" adherent mucus layer is largely devoid of bacteria. Defective mucus layers resulting from lack of MUC2 mucin, mutated Muc2 mucin vWF domains, or from deletion of core mucin glycosyltransferase enzymes in mice result in increased bacterial adhesion to the surface epithelium, increased intestinal permeability, and enhanced susceptibility to colitis caused by dextran sodium sulfate. Changes in mucin gene expression and mucin glycan structures occur in cancers of the intestine, contributing to diverse biologic properties involved in the development and progression of cancer. Further research is needed on identification and functional significance of various components of mucus layers and the complex interactions among mucus layers, microbiota, epithelial cells, and the underlying innate and adaptive immunity. Further elucidation of the regulatory mechanisms involved in mucin changes in cancer and inflammation may lead to the development of novel therapeutic approaches.

Indexed as

Adenocarcinoma, MucinousAnimalsCell CommunicationCystic FibrosisGoblet CellsHumansInfectionsInflammatory Bowel DiseasesIntercellular Signaling Peptides and ProteinsIntestinal MucosaIntestinal NeoplasmsIntestinesMiceMucinsPeptidesTrefoil Factor-2Intercellular Signaling Peptides and ProteinsMucinsPeptidesRETNLB protein, humanTrefoil Factor-2

Identifiers

PMID20703838
PMCPMC2933006
OpenAlexW2120950548

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.